Management of erectile dysfunction after radical prostatectomy

Urology

Volumn 66, Issue 5, 2005, Pages 923-929

  Raina, Rupesh ^b   Agarwal, Ashok ^b   Zippe, Craig D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC ADENOSINE MONOPHOSPHATASE; CYCLIC GUANOSINE MONOPHOSPHATASE; FORSKOLIN; MOXISYLYTE; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; UNCLASSIFIED DRUG; VARDENAFIL; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASODILATOR AGENT;

BURNING SENSATION; COITUS; DEVICE; DRUG COST; DRUG EFFICACY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; INJECTION PAIN; MALE GENITAL SYSTEM SURGERY; NAUSEA; NERVE GRAFT; NERVE REGENERATION; NERVE STIMULATION; NONHUMAN; PAIN; PATIENT COMPLIANCE; PATIENT SATISFACTION; PENILE FIBROSIS; PENIS; PENIS ERECTION; PENIS GLANS; PENIS PROSTHESIS; PRIORITY JOURNAL; PROSTATECTOMY; PROSTHESIS INFECTION; REVIEW; SENSORY DYSFUNCTION; SEXUAL INTERCOURSE; SEXUALITY; SURAL NERVE; TISSUE OXYGENATION; TREATMENT WITHDRAWAL; URETHRAL PAIN; VACUUM CONSTRICTION DEVICE;

COMBINED MODALITY THERAPY; FORECASTING; HUMANS; IMPOTENCE; MALE; PROSTATECTOMY;

EID: 27744523252     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.05.044     Document Type: Review

References (52)

1. C.L. Schrader-Bogan, J.L. Kjellberg, C.P. McPherson Quality of life and treatment outcomes prostate carcinoma patients' perspectives after prostatectomy or radiation therapy Cancer 79 1997 1977 1986
2. P.C. Walsh, P. Marschke, D. Ricker Patient-reported urinary continence and sexual function after anatomic radical prostatectomy Urology 55 2000 58 61
3. W.P. Catalona, J.W. Basler Return of erections and urinary continence following nerve-sparing radical retropubic prostatectomy J Urol 150 1993 905 907
4. D.M. Quinlan, J.I. Epstein, B.S. Carter Sexual function following radical prostatectomy influence of preservation of neurovascular bundles J Urol 145 1991 998 1002
5. J.P. Jarow, P. Nana-Sinkam, M. Sabbagh Outcome analysis of goal directed therapy for impotence J Urol 155 1996 1609 1612
6. J.P. Jarow, A.L. Burnett, A.M. Geringer Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment J Urol 162 1999 722 725
7. A.R. McCullough Erectile dysfunction after radical prostatectomy, hemodynamic profiles and their correlate with the recovery of erectile dysfunction J Urol 161 2002 1371 1375
8. M.S. Cookson, P.W. Nadig Long term results with vacuum constriction device J Urol 149 1993 290 294
9. T.C. Dutta, J.F. Eid Vacuum constriction devices for erectile dysfunction a long-term, prospective study of patients with mild, moderate, and severe dysfunction Urology 54 1999 891 893
10. A.A. Sidi, E.F. Becher, G. Zhang Patient acceptance of and satisfaction with an external negative pressure device for impotence J Urol 144 1990 1154 1156
11. H. Padma-Nathan, W.J. Hellstrom, F.E. Kaiser Treatment of men with erectile dysfunction with transurethral alprostadil N Engl J Med 336 1997 1 7
12. Paolone DR, Lakin MM, Ingleright BJ,, et al. Intraurethral alprostadil therapy at the Cleveland Clinic Foundation. Presented at the North Central Section American Urological Association Meeting in October 1998.
13. Raina R, Agarwal A, Ausmundson S,, et al. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res (in press).
14. W. Stakl, R. Hasun, N. Marberger Prostaglandin E-1 in the treatment of erectile dysfunction World J Urol 8 1990 84 86
15. M.A. Khan, C.S. Thompson, M.E. Sullivan The role of prostaglandins in the etiology and treatment of erectile dysfunction Prostaglandin Leukot Essent Fatty Acids 60 1999 169 174
16. 1 in patients with erectile dysfunction J Urol 158 1997 1403 1407
17. R.L. Dennis, W.S. McDougal Pharmacological treatment of erectile dysfunction after radical prostatectomy J Urol 139 1988 775 776
18. V.L. Rodriguez, I.A. Gonzalvo, A.A. Bono Erectile dysfunction after radical prostatectomy etiopathology and treatment Actas Urol Esp 21 1997 909 921
19. 1 a risk factor analysis J Urol 155 1996 139 140
20. C. Evans Complications of intracavernosal therapy for impotence C. Carson R. Kirby I. Goldstein Textbook of Erectile Dysfunction 1999 Isis Medical Media Oxford 365 370
21. J.P. Mulhall, A. Jahoda, M. Cairney The causes of patient dropout from penile self-injection therapy for impotence J Urol 162 1999 1291 1294
22. R. Raina, M.M. Lakin, A. Agarwal Long-term efficacy and compliance of intracavernous injections following radical prostatectomy SHIM (IIEF-5) analysis Int J Impot Res 15 2003 318 322
23. L.A. Turner, S.E. Althof, S.B. Levine Twelve-month comparison of two treatments for erectile dysfunction self-injection versus external vacuum devices Urology 39 1992 139 144
24. I. Goldstein, T.F. Lue, H. Padma-Nathan Sildenafil Study Group Oral sildenafil in the treatment of erectile dysfunction N Engl J Med 338 1998 1397 1404
25. G.P. Zagaja, D.A. Mhoon, J.E. Aikens Sildenafil in the treatment of erectile dysfunction after radical prostatectomy Urology 56 2000 631 634
26. M.I. Feng, S. Huang, J. Kaptein Effect of sildenafil citrate on post-radical prostatectomy erectile dysfunction J Urol 164 2000 1935 1938
27. C.D. Zippe, S. Kedia, A.W. Kedia Sildenafil citrate (Viagra) after radical retropubic prostatectomy pro Urology 54 1999 583 586
28. C.D. Zippe, F.M. Jhaveri, E.A. Klein Role of Viagra after radical prostatectomy Urology 55 2000 241 245
29. R. Raina, M.M. Lakin, A. Agarwal Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy 3-year follow-up Urology 62 2003 110 115
30. R. Raina, M.M. Lakin, A. Agarwal Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy Urology 63 2004 960 966
31. 1 and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy Int J Impot Res 14 suppl 1 2002 S38 S42
32. J.S. Jaffe, M.R. Antell, M. Greenstein Use of intraurethral alprostadil in patients not responding to sildenafil citrate Urology 63 2004 951 954
33. R. Raina, M.M. Lakin, A. Agarwal Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy Urology 63 2004 532 537
34. D.L. Gerstenberger, D. Osborne, W.L. Furlow Inflatable penile prosthesis follow-up study of patient-partner satisfaction Urology 14 1979 583 587
35. R.H. McLaren, D.M. Barrett Patient and partner satisfaction with the AMS 700 penile prosthesis J Urol 147 1992 62 65
36. W.J. Sexton, J.F. Benedict, J.P. Jarow Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy J Urol 159 1998 811 815
37. D.K. Montague, K.W. Angermeier Current status of penile prosthesis implantation Curr Urol Rep 1 2000 291 296
38. B.B. Garber, S.M. Marcus Does surgical approach affect the incidence of inflatable penile prosthesis infection? Urology 52 1998 291 293
39. J. Buvat, F. Montorsi Safety and tolerability of apomorphine SL in patients with erectile dysfunction BJU Int 88 suppl 3 2001 30 35
40. F. Montorsi, H.P. Nathan, A. McCullough Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy a randomized, double blind, placebo controlled trial J Urol 172 2004 1036 1041
41. H. Porst, J.M. Young, A.C. Schmidt Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups Urology 62 2003 519 523
42. G. Brock, A. Nehra, L. Lipshultz Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy J Urol 170 2003 1278 1283
43. R. Raina, K.C. Nandipati, A. Agarwal Comparison of the efficacy of sildenafil citrate, tadalafil, and vardenafil for the treatment of erectile dysfunction (ED) after radical prostatectomy (RP) (abstract) 2005 Presented at the Thirteenth Annual Meeting of the American Society of Andrology, Seattle, Washington.
44. L. Klotz, S. Herschorn Early experience with intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy Urology 52 1998 537 542
45. E.D. Kim, R. Nath, D. Kadmon Bilateral nerve graft during radical retropubic prostatectomy 1 year follow-up J Urol 165 2001 1950 1956
46. M.C. Fraiman, H. Lepor, A.R. McCullough Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical prostatectomy Mol Urol 3 1999 109 115
47. F. Montorsi, G. Guazzoni, L.F. Strambi Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil results of a prospective, randomized trial J Urol 158 1997 1408 1410
48. 1 suppresses the induction of collagen synthesis by transforming growth factor beta 1 in human corpus cavernosum smooth muscle J Urol 153 1998 811 815
49. H. Padma-Nathan Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy (abstract) J Urol 169 suppl 2003 375 376
50. R. Raina, A. Agarwal, C.D. Zippe Interim analysis of the early use of MUSE following radical prostatectomy (RP) to facilitate early sexual activity and return of spontaneous erectile function 2005 Abstract presented at the American Urological Association Meeting, May 24-29, San Antonio, Texas.
51. C.D. Zippe, R. Raina, A. Agarwal Recovery of spontaneous erectile function after radical prostatectomy with or without early use of VCD 2001 Abstract presented at the North Central Section American Urological Association Meeting, October 21-27, Cancun, Mexico.
52. M.C. Lee, A. El-Sakka, E. Bakircioglu The effect of vascular endothelial growth factor on a rat model of arterial impotence J Urol 167 2002 761 767